comparemela.com

Page 7 - Carlos De Sousa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ultimovacs Announces Completion of Exploratory Phase I TENDU Study of TET Vaccine Technology Platform Meeting the Primary Endpoint

  Dose-escalation, first-in-human Phase I trial showed good safety and tolerability across all dose-cohorts, meeting the primary endpointData included observations of immune activation with.

Ultimovacs ASA: Mandatory notification of trade by primary insider -November 21, 2023 at 11:01 am EST

Oslo, 21 November 2023, a closely related party of Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 500 shares in the company at an average price of NOK.

Argentina investors brace for financial pain no matter who wins presidency

Global investors expect a large amount of financial pain out of Argentina no matter who voters pick on Sunday as their next president, with social unrest as top of mind as a much-needed fiscal. -November 16, 2023 at 01:30 am EST - MarketScreener

Analysis-Argentina investors brace for financial pain no matter who wins presidency

Global investors expect a large amount of financial pain out of Argentina no matter who voters pick on Sunday as their next president, with social unrest as top of mind as a much-needed fiscal adjustment will likely trigger even more inflation. Economy minister Sergio Massa and populist outsider Javier Milei go head-to-head in the Nov. 19 presidential election run-off, a choice between sticking with the current Peronist government or a sharp swerve to a right-wing libertarian. "There is no room left to muddle through with the current economic policy stance, and the incoming president will have to take a turn in economic policy," Barclays' Latam economist Pilar Tavella said in a Wednesday note.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.